Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich's Ataxia
RNA sequencing of skeletal muscle biopsies from healthy controls and Friedreich's Ataxia (FRDA) patients before and after treatment with recombinant human erythropoietin (rhuEPO) to dissect the mechanisms of disease. Overall design: Comparison of seven healthy controls and seven FRDA patients before and after rhuEPO treatment.